☆ 4.6 Article

Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Hong Sun et al.

Summary: This study provides global, regional, and country-level estimates of diabetes prevalence and health expenditures for 2021 and projections for 2045. The global prevalence of diabetes is increasing and is expected to have the greatest relative increase in middle-income countries. Diabetes-related health expenditures are also projected to rise.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Add to Collection

Article Gastroenterology & Hepatology

Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease

Jennifer R. Kramer et al.

Summary: Patients with NAFLD and diabetes have a high risk of developing HCC. The study found that the use of metformin was associated with a reduced risk of developing HCC, while combination therapy was associated with an increased risk. Glycemic control can be a useful biomarker for stratifying HCC risk in these patients.

HEPATOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease

Fu-Shun Yen et al.

Summary: The global prevalence of chronic liver disease and diabetes mellitus has been increasing, leading to the complexity of choosing antidiabetic medications for patients with coexisting conditions. More research is needed to guide clinical practice in this area.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Review Gastroenterology & Hepatology

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review

Lei Miao et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with type 2 diabetes mellitus (T2DM) and T2DM is a risk factor for the progression of NAFLD to more severe conditions. Emerging evidence suggests that new types of glucose-lowering drugs may help slow down the progression of NAFLD.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Add to Collection

Review Endocrinology & Metabolism

Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance

Ashwani Sharma et al.

Summary: Dipeptidyl-peptidase-4 (DPP-4) is an enzyme with various properties and physiological roles. Up-regulation of hepatic DPP-4 expression may be the cause of glucose intolerance in individuals with liver conditions. This review focuses on the cleavage of alanine or proline-containing peptides by DPP-4 and its implications in glucose intolerance and liver diseases.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)

Add to Collection

Article Health Care Sciences & Services

Risk associations of long-term HbA1c variability and obesity on cancer events and cancer-specific death in 15,286 patients with diabetes - A prospective cohort study

Dandan Mao et al.

Summary: In diabetes, obesity and high glycaemic variability are associated with increased risks of all-site cancer, breast cancer, liver cancer, and cancer-specific death.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2022)

Add to Collection

Review Gastroenterology & Hepatology

Epidemiology of Hepatocellular Carcinoma

Katherine A. McGlynn et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major global health concern. While HBV and HCV remain important risk factors for HCC, efforts in vaccination and treatment are showing promise. However, the increasing prevalence of metabolic risk factors like obesity and diabetes, as well as other factors like excessive alcohol consumption, present ongoing challenges in the prevention of liver cancer.

HEPATOLOGY (2021)

Add to Collection

Article Cell Biology

Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway

Xin Wang et al.

Summary: Sitagliptin protects liver tissue in diabetic mice by inhibiting DPP4 activity, reducing cytokines, oxidative stress, cell apoptosis, and inflammation. Additionally, sitagliptin decreases cellular ROS levels and protein expression in the NF kappa B signaling pathway, providing a potential mechanism for preventing diabetic liver disease.

CELL DEATH DISCOVERY (2021)

Add to Collection

Article Endocrinology & Metabolism

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco et al.

Summary: This study assessed the prevalence of NAFLD and liver fibrosis in patients with type 2 diabetes mellitus, revealing that at least 15% of patients with T2DM and NAFLD have moderate-to-advanced fibrosis. Screening for liver disease can be enhanced using imaging and plasma diagnostic panels, as AST/ALT alone are inadequate as initial screening markers.

DIABETES CARE (2021)

Add to Collection

Review Gastroenterology & Hepatology

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis

Cori Campbell et al.

Summary: Hepatocellular carcinoma (HCC) is a major cause of cancer mortality globally, particularly in individuals with chronic hepatitis B virus (HBV) infection. Research shows that diabetes mellitus (DM) is significantly associated with an increased risk of HCC, emphasizing the need for enhanced screening of HBV and diabetic patients.

JOURNAL OF VIRAL HEPATITIS (2021)

Add to Collection

Article Medicine, General & Internal

Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes

Junqing Xie et al.

Summary: In this study, new prescription dispensation of tramadol was significantly associated with a higher risk of all-cause mortality, cardiovascular events, and fractures compared to codeine, with no significant differences in the risk of other adverse outcomes. The findings emphasize the importance of cautious interpretation due to potential residual confounding.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats

Hui-Chun Huang et al.

Summary: The DPP-4 inhibitor linagliptin significantly reduced portal pressure in portal hypertensive rats but had no significant effect in cirrhotic rats. This may be achieved by upregulating hepatic nitric oxide synthase expression to decrease intrahepatic resistance in portal hypertensive rats.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Medicine, Research & Experimental

DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility

Xinxin Wang et al.

Summary: The study aimed to investigate the effects of DPP4i on cirrhotic rats' contractile response, splanchnic hemodynamics, and portal pressure. Results showed that sitagliptin significantly reduced portal blood flow and pressure, reversed the decreased response of mesenteric arterioles, and suppressed Nox4 expression and ROS production. Overall, DPP4 inhibition by sitagliptin has beneficial effects on portal hypertension in cirrhotic rats, suggesting a potential novel strategy for treating patients with cirrhosis and portal hypertension.

LIFE SCIENCES (2021)

Add to Collection

Article Gastroenterology & Hepatology

High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection

Shingo Shimada et al.

Summary: HCC patients with high HbA1c may have poor prognoses in NBNC-HCC, while metformin could be a good option for treating these patients.

HEPATOBILIARY SURGERY AND NUTRITION (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan

Wei-Hao Hsu et al.

Summary: The study found that the use of DPP-4 inhibitors was associated with a lower risk of hepatocellular carcinoma in patients with type 2 diabetes and chronic HCV infection.

FRONTIERS IN PUBLIC HEALTH (2021)

Add to Collection

Article Medicine, General & Internal

Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats

Hui-Chun Huang et al.

Summary: Linagliptin reduced portal pressure in portal hypertensive rats by upregulating nitric oxide synthase expression, but had insignificant effect in cirrhotic rats. Linagliptin treatment did not significantly impact glucose plasma levels, liver biochemistry parameters, and portal-systemic shunting.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)

Add to Collection

Review Microbiology

Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

Mindie H. Nguyen et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Add to Collection

Review Oncology

Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis

Paramita Dasgupta et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Validity of ICD-10-CM Codes Used to Identify Patients with Chronic Hepatitis B and C Virus Infection in Administrative Claims Data from the Taiwan National Health Insurance Outpatient Claims Dataset

Ming-Jen Sheu et al.

CLINICAL EPIDEMIOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B

Terry Cheuk-Fung Yip et al.

JOURNAL OF VIRAL HEPATITIS (2020)

Add to Collection

Review Pediatrics

Elimination of Mother-to-Infant Transmission of Hepatitis B Virus: 35 Years of Experience

Fang-Ting Lu et al.

PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2020)

Add to Collection

Article Medicine, General & Internal

Taiwan's Nationwide Cancer Registry System of 40 years: Past, present, and future

Chun-Ju Chiang et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Medicine, General & Internal

Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan

Yi-Jing Sheen et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Endocrinology & Metabolism

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes

Fu-Shun Yen et al.

BMC ENDOCRINE DISORDERS (2019)

Add to Collection

Review Oncology

Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review

Yifei Tan et al.

CANCER MANAGEMENT AND RESEARCH (2019)

Add to Collection

Article Gastroenterology & Hepatology

Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice

Sohji Nishina et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Review Chemistry, Medicinal

Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus

Ning Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Mother-to-infant transmission of hepatitis B virus: challenges and perspectives

Yi-Fen Shih et al.

HEPATOLOGY INTERNATIONAL (2017)

Add to Collection

Review Gastroenterology & Hepatology

Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus

Yoshio Sumida et al.

HEPATOLOGY RESEARCH (2017)

Add to Collection

Article Gastroenterology & Hepatology

Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients

Jung Hee Kim et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan: An 8-year population-based study

Wei-Min Chu et al.

MEDICINE (2017)

Add to Collection

Review Biochemical Research Methods

Eradicating hepatitis B virus: The critical role of preventing perinatal transmission

Cladd E. Stevens et al.

BIOLOGICALS (2017)

Add to Collection

Review Oncology

Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease

Alessandro Mantovani et al.

ANNALS OF TRANSLATIONAL MEDICINE (2017)

Add to Collection

Review Gastroenterology & Hepatology

Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis

Siddharth Singh et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Add to Collection

Article Immunology

Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients With Newly Diagnosed Diabetes: A Nationwide Cohort Study

Yi-Wen Huang et al.

CLINICAL INFECTIOUS DISEASES (2013)

Add to Collection

Article Gastroenterology & Hepatology

Diabetes, hepatitis virus infection and hepatocellular carcinoma: A case-control study in hepatitis endemic area

Wei-Hsu Ko et al.

HEPATOLOGY RESEARCH (2012)

Add to Collection

Article Gastroenterology & Hepatology

Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-up Study

Jessica Liu et al.

GASTROENTEROLOGY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.